Harbor Capital Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.16M Buy
135,985
+44,465
+49% +$777K 0.17% 161
2025
Q4
$1.63M Sell
91,520
-13,169
-13% -$231K 0.13% 226
2025
Q3
$1.94M Sell
104,689
-229,270
-69% -$4.72M 0.15% 177
2025
Q2
$7.17M Buy
333,959
+179,733
+117% +$3.89M 0.3% 104
2025
Q1
$3.8M Sell
154,226
-97,362
-39% -$2.4M 0.17% 187
2024
Q4
$5.83M Buy
251,588
+4,728
+2% +$118K 0.25% 123
2024
Q3
$6.69M Buy
246,860
+179,803
+268% +$5.45M 0.29% 102
2024
Q2
$1.93M Buy
67,057
+58,104
+649% +$1.78M 0.15% 211
2024
Q1
$261K Buy
+8,953
New +$250K 0.03% 549
2023
Q3
Sell
-477
Closed -$20.9K 549
2023
Q2
$20.9K Buy
+477
New +$22K ﹤0.01% 592

Other funds holding KIDS

Harbor Capital Advisors's KIDS Position: Q1 2026 in Review

Harbor Capital Advisors increased its OrthoPediatrics (KIDS) stake by 49% in Q1 2026, buying an estimated $777K and bringing the position to 135,985 shares worth $2.16M. The position accounts for 0.17% of the portfolio, ranked #161.

Harbor Capital Advisors first reported a position in KIDS in Q2 2023 and has held it in 10 quarters since. The position peaked at $7.17M in Q2 2025. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Harbor Capital Advisors held 135,985 shares of OrthoPediatrics worth $2.16M as of Q1 2026.
  • Harbor Capital Advisors bought 44,465 OrthoPediatrics shares in Q1 2026, an estimated $777K.
  • OrthoPediatrics made up 0.17% of Harbor Capital Advisors's portfolio in Q1 2026, its #161 holding.
  • Harbor Capital Advisors first reported a position in OrthoPediatrics in Q2 2023 and has held it in 10 quarters since.
  • Harbor Capital Advisors's OrthoPediatrics position peaked at $7.17M in Q2 2025.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.